Health Canada drug identification number

DIN 02384256 — XALKORI 200 MG

XALKORI is a capsule of Crizotinib marketed by PFIZER CANADA ULC. The full Crizotinib monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02384256
Brand name
XALKORI
Active ingredient
Crizotinib
Strength
200 MG
Dosage form
CAPSULE
Route
ORAL
Manufacturer
PFIZER CANADA ULC
Health Canada status
MARKETED
Drug class
Protein kinase inhibitor (ALK/ROS1 inhibitor)

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Other Crizotinib products

DINBrandStrengthFormManufacturerStatus
02384264 XALKORI 250 MG CAPSULE PFIZER CANADA ULC MARKETED

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.